26 related articles for article (PubMed ID: 33491495)
1. Impact of red blood cell distribution width-albumin ratio on prognosis of patients with CKD.
Kimura H; Tanaka K; Saito H; Iwasaki T; Kazama S; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
Sci Rep; 2023 Sep; 13(1):15774. PubMed ID: 37737253
[TBL] [Abstract][Full Text] [Related]
2. Red blood cell distribution width and renal cell carcinoma: A comparative analysis of peer-reviewed studies.
Frater JL; Hurley MY
Transl Oncol; 2022 Dec; 26():101558. PubMed ID: 36228409
[No Abstract] [Full Text] [Related]
3. Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma.
Aktepe OH; Güner G; Güven DC; Taban H; Yıldırım HÇ; Şahin TK; Ardıç FS; Yeter HH; Yüce D; Erman M
Turk J Urol; 2021 Mar; 47(2):113-119. PubMed ID: 33819441
[TBL] [Abstract][Full Text] [Related]
4. Cellular and physical microenvironments regulate the aggressiveness and sunitinib chemosensitivity of clear cell renal cell carcinoma.
Nagase K; Akutagawa T; Rikitake-Yamamoto M; Morito S; Futamata M; Tobu S; Noguchi M; Toda S; Aoki S
J Pathol; 2021 May; 254(1):46-56. PubMed ID: 33512712
[TBL] [Abstract][Full Text] [Related]
5. Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy.
Guven DC; Aksun MS; Sahin TK; Aktepe OH; Yildirim HC; Taban H; Ceylan F; Kertmen N; Arik Z; Dizdar O; Kilickap S; Aksoy S; Yalcin S; Erman M
Support Care Cancer; 2021 Sep; 29(9):5417-5423. PubMed ID: 33709186
[TBL] [Abstract][Full Text] [Related]
6. External validation of a red cell-based blood prognostic score in patients with metastatic renal cell carcinoma treated with first-line immunotherapy combinations.
Maffezzoli M; Santoni M; Mazzaschi G; Rodella S; Lai E; Maruzzo M; Basso U; Bimbatti D; Iacovelli R; Anghelone A; Fiala O; Rebuzzi SE; Fornarini G; Lolli C; Massari F; Rosellini M; Mollica V; Nasso C; Acunzo A; Silini EM; Quaini F; De Filippo M; Brunelli M; Banna GL; Rescigno P; Signori A; Buti S
Clin Exp Metastasis; 2024 Apr; 41(2):117-129. PubMed ID: 38363410
[TBL] [Abstract][Full Text] [Related]
7. The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study.
Tommasi C; Scartabellati G; Giannarelli D; Giorgi U; Brighi N; Fornarini G; Rebuzzi SE; Puglisi S; Caffo O; Kinspergher S; Mennitto A; Cattrini C; Santoni M; Verzoni E; Rametta A; Stellato M; Malgeri A; Roviello G; Brunelli M; Buti S
Ther Adv Urol; 2023; 15():17562872231187216. PubMed ID: 37492625
[TBL] [Abstract][Full Text] [Related]
8. Preoperative red blood cell distribution width as an independent prognostic factor in metastatic renal cell carcinoma.
Wei Z; Zhang F; Ma X; He W; Gou X; Zhang X; Xie Y
Transl Oncol; 2022 Sep; 23():101486. PubMed ID: 35839619
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell distribution width at admission predicts outcome in critically ill patients with kidney failure: a retrospective cohort study based on the MIMIC-IV database.
Hua R; Liu X; Yuan E
Ren Fail; 2022 Dec; 44(1):1182-1191. PubMed ID: 35834358
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category.
Davis ID; Xie W; Pezaro C; Donskov F; Wells JC; Agarwal N; Srinivas S; Yuasa T; Beuselinck B; Wood LA; Ernst DS; Kanesvaran R; Knox JJ; Pantuck A; Saleem S; Alva A; Rini BI; Lee JL; Choueiri TK; Heng DYC
Eur Urol; 2017 Jun; 71(6):970-978. PubMed ID: 27771126
[TBL] [Abstract][Full Text] [Related]
11. Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score.
Mazzaschi G; Lazzarin A; Santoni M; Trentini F; Giorgi U; Brighi N; Tommasi C; Puglisi S; Caffo O; Kinspergher S; Mennitto A; Cattrini C; Verzoni E; Rametta A; Stellato M; Malgeri A; Roviello G; Silini EM; Rescigno P; Rebuzzi SE; Fornarini G; Quaini F; Giudice GC; Banna GL; Buti S
Front Biosci (Elite Ed); 2023 Jul; 15(3):20. PubMed ID: 37743233
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Predictive Power of the Hemoglobin/Red Cell Distribution Width Ratio in Cancer: A Systematic Review and Future Directions.
Coradduzza D; Medici S; Chessa C; Zinellu A; Madonia M; Angius A; Carru C; De Miglio MR
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138227
[No Abstract] [Full Text] [Related]
13. The Predictive Value of Red Blood Cell Distribution Width for Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapy.
Aktepe OH; Guven DC; Sahin TK; Yildirim HC; Celikten B; Yeter HH; Yuce D; Dizdar O; Erman M
Nutr Cancer; 2021; 73(10):1957-1963. PubMed ID: 33491495
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK
Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622
[TBL] [Abstract][Full Text] [Related]
15. First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Ruiz-Morales JM; Swierkowski M; Wells JC; Fraccon AP; Pasini F; Donskov F; Bjarnason GA; Lee JL; Sim HW; Sliwczynsk A; Ptak-Chmielewska A; Teter Z; Beuselinck B; Wood LA; Yuasa T; Pezaro C; Rini BI; Szczylik C; Choueiri TK; Heng DY
Eur J Cancer; 2016 Sep; 65():102-8. PubMed ID: 27487293
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
